Inversago Pharma, based in Montreal, Canada, is working on safer generations of peripherally-acting cannabinoid receptor-1 (CB1) inverse agonists, based on research carried out by George Kunos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback